For patients with muscle-invasive urothelial carcinoma, an oncology trial has shown promising results.

Published Date: 31 Jan 2024

A novel treatment option may be available to patients with muscle-invasive urothelial cancer who have a high risk of recurrence following surgery. Results from the Phase III AMBASSADOR have been declared positive by the Alliance for Clinical Trials in Oncology.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot